Stemtech Corporation
STEK
$0.00
$0.005.26%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 22.12% | -19.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.12% | -19.60% | |||
| Cost of Revenue | 16.38% | -1.29% | |||
| Gross Profit | 23.64% | -23.37% | |||
| SG&A Expenses | 19.78% | -55.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.28% | -51.81% | |||
| Operating Income | -12.69% | 75.02% | |||
| Income Before Tax | -174.22% | 79.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -174.22% | 79.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 0.00% | |||
| Net Income | -176.15% | 79.86% | |||
| EBIT | -12.69% | 75.02% | |||
| EBITDA | -14.74% | 77.72% | |||
| EPS Basic | -157.14% | 82.93% | |||
| Normalized Basic EPS | -161.54% | 83.12% | |||
| EPS Diluted | -376.19% | 82.93% | |||
| Normalized Diluted EPS | -161.54% | 83.12% | |||
| Average Basic Shares Outstanding | 5.38% | 20.01% | |||
| Average Diluted Shares Outstanding | 5.38% | 20.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||